Hormonal Changes in Early Pregnancy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-01-18

Study Completion Date

2014-04-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will analyze hormones in early pregnancy. Hormonal changes in early pregnancy reflect the quality of implantation in the uterus of the fertilized egg, the function of the corpus luteum (mass of hormone-secreting tissue that forms immediately after ovulation) and placenta, and the health of the embryo. It will determine the following:

* Whether early pregnancy hormones vary by characteristics of the mother
* Whether early pregnancy hormones differ for pregnancies with male or female babies
* Whether early pregnancy hormones can predict the gestational age (age of the baby during pregnancy) and the baby's birth weight
* Hormone activity at the time pregnancy symptoms begin
* How the contribution of the corpus luteum changes during the pregnancy in different women

Stored urine specimens collected from women who participated in the North Carolina Early Pregnancy Study in the 1980s will be used for this study. In addition, to evaluate the quality of the stored samples, new specimens will be collected from women currently enrolled in the University of North Carolina's Right from the Start study. Candidates must be white women not of Latino or Hispanic origin who are between 25 and 35 years of age and who are planning to become pregnant within a few months' time. They must be non-smokers, have regular menstrual cycles, no known fertility problems and no major chronic disease.

Urine specimens are analyzed for hormone levels and other changes in early pregnancy that can be measured in urine. Women providing new urine specimens do the following:

Pre-Pregnancy

The pre-pregnancy part of the study lasts through no more than three consecutive menstrual cycles. Participants who do not become pregnant after three menstrual cycles end the study at that time.

* Have a short interview with a study staff member
* Complete a daily diary, recording any vaginal bleeding or spotting, health status, and use of medications, and mail the diary to the study office once a week
* Use an ovulation testing kit for up to 7 days during their menstrual cycle
* Call the study staff within the first 24 hours of becoming pregnant

Pregnancy

The pregnancy part of the study lasts about 5 weeks.

* Continue to complete daily diary records for weekly pickup by staff member
* Collect urine samples daily and store them in the freezer for weekly pickup by staff member
* Have 1 to 2 tablespoons of blood drawn at home weekly for 4 weeks
* Have a brief follow-up telephone interview around week 12 of their pregnancy

Urine samples are analyzed for hormones such as human chorionic gonadotropin, estrone-3-glucuronide, and pregnanedrol glucuronide. White blood cells are stored for DNA to study such things as genes controlling hormone metabolism.

...

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Follow-up of the Early Pregnancy Study Cohort.

NCT01132924

Gestational Age Time to Pregnancy Early Pregnancy Loss

COMPLETED

Early Pregnancy Evaluation by Three-Dimensional Ultrasound

NCT00342290

First Trimester Bleeding Pregnancy

TERMINATED

Prevalence of Ambivalence Regarding Prenatal Testing

NCT00342069

Pregnancy

COMPLETED

Measuring hCG Levels in Pregnant Women

NCT02763176

hCG

COMPLETED

Posturography Changes During Pregnancy

NCT03067116

Pregnant Women

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Daily first morning urine specimens were collected throughout the first 8-9 weeks of 151 clinical pregnancies. These specimens are now approximately 20 years in storage, and the stability of markers of placental and corpus luteum function are not known. We will collect new urine specimens for 20 pregnancies to serve as a reference to evaluate the quality of those stored samples.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Women in Early Pregnancy

Women enrolled in the University of North Carolina's Right from the Start study are followed while trying to become pregnant and through 9 weeks of pregnancy

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

We will recruit from the pre-pregnancy participants in the Right From the Start UNC study entitled, Consequences and Course of Uterine Fibroid in Pregnancies.

The women will be selected to be similar to the majority of women in the NC-EPS because we need to have a comparable sample of women in order to best compare hormone levels.

Entry requirements will be:

white (including Hispanic and latino), age 25-35, regular menstrual cycles, nonsmoker (i.e., no smoking in past year), no major chronic disease, no known fertility problems, no more than 3 months of trying for this current pregnancy.

Minimum Eligible Age

25 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No